From Name

From Email

To Name

To Email

Message

Alnylam Paints Fuller Picture for Kidney Disease Drug Lumasiran with Positive Data

from FierceBiotech

Alnylam Paints Fuller Picture for Kidney Disease Drug Lumasiran with Positive Data FierceBiotech With a Federal Drug Administration decision to come by the end of the year, Alnylam is offering a closer look at its RNA-silencing treatment for a rare kidney disorder. The drug, lumasiran, beat placebo at helping patients clear a substance called oxalate from their kidneys and lowered most patients’ oxalate levels to normal or near-normal amounts. READ MORE

more